Trader TV Watchlist - December 9, 2025

Tuesday December 9, 2025

Welcome to the TraderTV Live Morning Research Note. Here's what's making major moves in the market today.

TraderTV.LIVE™ features a daily live trading broadcast, professional education and an active community of more than 450,000 subscribers. Join us on YouTube every weekday from 8:30am to 4:30pm EST for the first and only professional trading show on YouTube Live!

Economic Events:

1000 - JOLTs job openings for September: Expected 7M; Prior 7.227M
1000 - JOLTs job openings for October: Expected 7.2M

Premarket Trading:

Trading Higher ($): NVDA, INTC, DBI

Trading Lower ($): TSLA, MARA, BYND

Earnings Today:

Premarket: SAIL, AZO, CPB

Post-market: GME, CBRL, PLAY

In The News

NVIDIA Corp, Advanced Micro Devices, and Intel

+0.68%

All three stocks are on watch after US President Donald Trump announced that the US will allow Nvidia’s H200 AI chips to be exported to China with a 25% fee. The move resolves months of internal debate over balancing US chip leadership with national security, though it’s unclear how much demand will materialize given Beijing’s push to avoid US technology. Trump indicated that similar rules will apply to AMD and Intel.

NVDA, AMD, INTC

Alphabet Inc (GOOGL)

-0.37%

The EU has launched an antitrust investigation into the company over concerns that it may be using publishers’ web content and YouTube videos to train its AI models without proper compensation or a meaningful ability to opt out. Regulators say Google could be abusing its dominance by imposing unfair terms and using this content to power features like AI Overviews, potentially harming publishers and distorting competition in emerging AI markets.

Meta Platforms Inc (META)

-0.50%

CNBC reported that the company is pushing to release its next major AI model, “Avocado,” in early 2026 after internal delays tied to training and performance testing. This update comes amid concerns that Meta’s AI strategy lacks cohesion compared to faster-moving rivals. With the stock lagging and capex rising to as much as $72 billion for 2025—after a $14.3B talent grab from Scale AI—investors are increasingly seeking clarity on how Meta plans to translate its massive AI spend into returns.

Micron Technology Inc (MU)

-0.74%

HSBC initiated coverage of the stock with a Buy rating and a $330 price target, arguing the market is underestimating both the DRAM upcycle and Micron’s coming surge in enterprise solid-state drive (eSSD) share. The analyst projects a 125% operating profit CAGR through FY27 driven by factors including DRAM price strength, 1γ node cost gains, and premium HBM4 adoption.

Tesla Inc (TSLA)

-0.57%

Electrek reported that the company just launched its strongest year-end incentives yet. These offerings reportedly include 0% APR for 72 months on Model 3/Y, $0-down Model Y leases, and free option upgrades on select inventory for deliveries before December 31. The move has been interpreted as a Q4 inventory push following the expiration of the $7,500 EV credit.

Critical Metals Corp (CRML)

+4.10%

Trading sharply higher premarket after announcing a 50/50 joint venture with Romania’s FPCU to build a rare earth processing plant that will handle 50% of Tanbreez’s concentrate for the life of the mine. This partnership will allow for the production of high-grade metals and magnets while targeting EU critical-materials funding. Critical Metals retains half of the JV without contributing build capex and plans to release an updated feasibility study by Q1 2026.

CoreWeave Inc (CRWV)

-1.15%

The company priced a private offering of $2.25 billion in 1.75% convertible senior notes due 2031, up from an initially announced $2 billion. The notes, guaranteed by CoreWeave’s subsidiaries, will accrue 1.75% annual interest payable semiannually and mature on December 1, 2031, unless repurchased, redeemed, or converted.

Norwegian Cruise Line Holdings Ltd (NCLH)

-1.62%

Trading lower premarket after Goldman Sachs downgraded the stock to Neutral from Buy and cut its price target to $21 from $23, citing a less favorable risk-reward for 2026. The firm highlighted NCLH’s heavy exposure to the Caribbean, where supply is outpacing demand, likely pressuring near-term net yields despite long-term brand investments and new ships.

Microsoft Corp (MSFT)

+0.06%

The company announced a $19 billion CAD investment in Canada through 2027, including $7.5 billion CAD in the next two years, to rapidly expand AI and cloud infrastructure starting in late 2026. Microsoft is also launching a five-point digital sovereignty plan and doubling down on nationwide talent development, reinforcing its deep economic footprint across Canadian partners, jobs, and communities.

Ollie’s Bargain Outlet Holdings Inc (OLLI)

-6.57%

Gapping down after its Q3 2025 earnings report. Adjusted earnings of $0.75 per share beat estimates of $0.73, though sales of $613.619 million narrowly missed estimates of $614.397 million. The company raised its adjusted EPS outlook for FY25 to $3.81-$3.87, compared to estimates of $3.85. Ollie’s also raised its FY25 sales outlook to $2.648 billion-$2.655 billion, beating estimates of $2.644 billion.

Netflix Inc (NFLX)

+0.18%

On watch after UBS weighed in on the company’s proposed deal with Warner Bros Discovery. The analyst argued that a combined Netflix + WBD/HBO Max would lift Netflix’s U.S. TV share to approximately 9.2%, with content spend near $30B and ad revenue expected to more than double in 2025. UBS noted that Netflix management expressed high confidence in regulatory approval, highlighted major benefits from WBD content, and emphasized accelerating momentum in areas like advertising and AI-driven personalization.

Designer Brands Inc (DBI)

+20.21%

Gapping up after its Q3 2025 earnings report. Adjusted earnings of $0.38 per share beat estimates of $0.18, though sales of $752.411 million missed estimates of $763.4 million. The company guided adjusted operating profit between $50 million and $55 million for FY25,

Senti Biosciences Inc (SNTI)

+36.40%

Gapping up after announcing that the FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to SENTI-202, its potential first-in-class off-the-shelf CAR-NK cell therapy for relapsed/refractory hematologic malignancies, including AML. The stock has a market capitalization of $62.84 million and a float of 6.7 million shares.